Obsessive-compulsive disorder. Anxiety disorder
Conditions
Interventions
Intervention 1: Intervention group: risperidone is started at 0.5 mg/d in the first week and then is elevated to 1 mg/d in the second week and is continued until the end of the third month. Interventi
Treatment - Drugs
Placebo
Intervention group: risperidone is started at 0.5 mg/d in the first week and then is elevated to 1 mg/d in the second week and is continued until the end of the third month.
Control group: identical to that of risperidone.
Sponsors
Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: obsessive compulsive disorder, New case , age>18, age16. Exclusion criteria: substance abuse, comorbid of psychotic disorder, suicidal ideation, Yale Brown rating.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment. Timepoint: Before treatment, 6weeks after treatment , 12weeks after treatment. Method of measurement: Obsessive compulsive qustioner (Y-Bocs). | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical side effects. Timepoint: 6 and 12 weeks after treatment. Method of measurement: According to patients report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fahimeh Jahandar Lashaki
Farabi Hospital of Kermanshah
Outcome results
None listed